Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2012 (2012), Article ID 827543, 4 pages
http://dx.doi.org/10.1155/2012/827543
Case Report

A Case of Microangiopathic Antiphospholipid-Associated Syndromes during Pregnancy: Review of the Literature

1Department of Obstetrics and Gynecology, Nagoya City University, Graduate School of Medicine, Nagoya 467-8601, Japan
2Division of Clinical and Molecular Genetics, Nagoya City University, Graduate School of Medicine, Nagoya 467-8601, Japan
3Department of Cardio-Renal Medicine and Hypertension, Nagoya City University, Graduate School of Medicine, Nagoya 467-8601, Japan

Received 29 March 2012; Accepted 25 April 2012

Academic Editor: Yasuhiko Sugawara

Copyright © 2012 Nobuhiro Suzumori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. W. M. Derksen, M. A. Khamashta, and D. W. Branch, “Management of the obstetric antiphospholipid syndrome,” Arthritis and Rheumatism, vol. 50, no. 4, pp. 1028–1039, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Appenzeller, F. H. Souza, A. Wagner Silvia de Souza, Y. Shoenfeld, and J. F. de Carvalho, “HELLP syndrome and its relationship with antiphosphplipid syndrome and antiphospholipid antibodies,” Seminars in Arthritis and Rheumatism, vol. 41, pp. 517–523, 2011. View at Google Scholar
  4. R. Pauzner, M. Dulitzky, H. Carp et al., “Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome,” Journal of Thrombosis and Haemostasis, vol. 1, no. 8, pp. 1758–1763, 2003. View at Google Scholar · View at Scopus
  5. R. A. Asherson, S. Pierangeli, and R. Cervera, “Microangiopathic antiphospholipid-associated syndromes revisited—new concepts relating to antiphospholipid antibodies and syndromes,” Journal of Rheumatology, vol. 34, no. 9, pp. 1793–1795, 2007. View at Google Scholar · View at Scopus
  6. T. M. Rahman and J. Wendon, “Severe hepatic dysfunction in pregnancy,” Monthly Journal of the Association of Physicians, vol. 95, no. 6, pp. 343–357, 2002. View at Google Scholar · View at Scopus
  7. Y. Wada, Y. Sakamaki, D. Kobayashi et al., “HELLP syndrome, multiple liver infarctions, and intrauterine fetal death in a patient with systemic lupus erythematosus and antiphospholipid syndrome,” Internal Medicine, vol. 48, no. 17, pp. 1555–1558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ogasawara, K. Aoki, E. Matsuura, H. Sasa, and Y. Yagami, “Anti β2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss: prevalence and clinical significance,” Lupus, vol. 5, no. 6, pp. 587–592, 1996. View at Google Scholar · View at Scopus
  9. J. A. Gómez-Puerta, J. Sanin-Blair, and C. Galarza-Maldonado, “Pregnancy and catastrophic antiphospholipid syndrome,” Clinical Reviews in Allergy and Immunology, vol. 36, no. 2-3, pp. 85–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Branch, “Report of the obstetric APS task force: 13th international congress on antiphospholipid antibodies, 13th April 2010,” Lupus, vol. 20, no. 2, pp. 158–164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. W. S. Symmers, “Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy),” British Medical Journal, vol. 2, no. 4790, pp. 897–903, 1952. View at Google Scholar · View at Scopus
  12. G. Espinosa, S. Bucciarelli, R. Cervera et al., “Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies,” Annals of the Rheumatic Diseases, vol. 63, no. 6, pp. 730–736, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Le Thi Thuong, N. Tieulié, N. Costedoat et al., “The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 in 15 women,” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. 273–278, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. S. Pierangeli, M. Colden-Stanfield, X. Liu, J. H. Barker, G. L. Anderson, and E. N. Harris, “Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo,” Circulation, vol. 99, no. 15, pp. 1997–2002, 1999. View at Google Scholar · View at Scopus
  15. S. S. Pierangeli, R. G. Espinola, X. Liu, and E. N. Harris, “Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin,” Circulation Research, vol. 88, no. 2, pp. 245–250, 2001. View at Google Scholar · View at Scopus
  16. P. L. Meroni, E. Raschi, C. Testoni, and M. O. Borghi, “Endothelial cell activation by antiphospholipid antibodies,” Clinical Immunology, vol. 112, no. 2, pp. 169–174, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. J. Hulstein, P. J. van Runnard Heimel, A. Franx et al., “Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome,” Journal of Thrombosis and Haemostasis, vol. 4, no. 12, pp. 2569–2575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Zhou, A. S. Wolberg, and R. A. S. Roubey, “Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep,” Blood, vol. 104, no. 8, pp. 2353–2358, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. E. Vega-Ostertag, E. N. Harris, and S. S. Pierangeli, “Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin,” Arthritis and Rheumatism, vol. 50, no. 9, pp. 2911–2919, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. D. W. Branch, M. Gibson, and R. M. Silver, “Recurrent miscarriage,” The New England Journal of Medicine, vol. 363, no. 18, pp. 1740–1747, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. N. Magnani, “An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran),” Thrombosis Research, vol. 125, no. 4, pp. 297–302, 2010. View at Publisher · View at Google Scholar · View at Scopus